Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Mahmood

Showing results (291-300 of 309) with videos related to

Pageof 31
Sort By:
Leukemia|July 17, 2014
A matched comparison of cyclophosphamide, bortezomib and dexamethasone (CVD) versus risk-adapted cyclophosphamide, thalidomide and dexamethasone (CTD) in AL amyloidosisC P Venner, J D Gillmore, S Sachchithanantham, et al.
Eye (London, England)|April 18, 2015
Defining response to anti-VEGF therapies in neovascular AMDW M Amoaku, U Chakravarthy, R Gale, et al.
Radiology. Cardiothoracic Imaging|March 29, 2021
Imaging Utilization and Outcomes in Vulnerable Populations during COVID-19 in New York CityDennis Toy, Syed S Mahmood, Jessica Rotman, et al.
British Journal of Haematology|July 24, 2023
Haematopoietic stem cell mobilisation followed by high-dose chemotherapy and autologous stem cell transplantation for patients with sickle cell disease and myelomaS Asher, R Shah, S Ings, et al.
Journal of the American College of Cardiology|March 24, 2018
Myocarditis in Patients Treated With Immune Checkpoint InhibitorsSyed S Mahmood, Michael G Fradley, Justine V Cohen, et al.
Clinical Radiology|November 26, 2025
Utility of diffusion-weighted signal intensity ratio measurements for predicting malignancy in adnexal mass lesions and its comparison with ORADS MRI scoring: Can an abbreviated MRI protocol predict malignancy accurately?N S Mahmood, A A Al Rashid, S B Ladumor, et al.
British Journal of Haematology|May 12, 2024
Atrial arrhythmias following CAR-chimeric antigen receptor T-cell therapy: Incidence, risk factors and biomarker profileRoni Shouval, Adam Goldman, Jessica R Flynn, et al.
Journal of the American College of Cardiology|December 21, 2019
Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T)Raza M Alvi, Matthew J Frigault, Michael G Fradley, et al.
Cancer Research|July 7, 2026
Targeting Cystine Addiction Suppresses Breast Cancer Lung MetastasisJosep Tarragó-Celada, Asad S Mahmood, Yulia Panina, et al.
JAMA|August 8, 2023
Atorvastatin for Anthracycline-Associated Cardiac Dysfunction: The STOP-CA Randomized Clinical TrialTomas G Neilan, Thiago Quinaglia, Takeshi Onoue, et al.
Pageof 31

Showing results (291-300 of 309) with videos related to

Sort By:
Pageof 31
Leukemia|July 17, 2014
A matched comparison of cyclophosphamide, bortezomib and dexamethasone (CVD) versus risk-adapted cyclophosphamide, thalidomide and dexamethasone (CTD) in AL amyloidosisC P Venner, J D Gillmore, S Sachchithanantham, et al.
Eye (London, England)|April 18, 2015
Defining response to anti-VEGF therapies in neovascular AMDW M Amoaku, U Chakravarthy, R Gale, et al.
Radiology. Cardiothoracic Imaging|March 29, 2021
Imaging Utilization and Outcomes in Vulnerable Populations during COVID-19 in New York CityDennis Toy, Syed S Mahmood, Jessica Rotman, et al.
British Journal of Haematology|July 24, 2023
Haematopoietic stem cell mobilisation followed by high-dose chemotherapy and autologous stem cell transplantation for patients with sickle cell disease and myelomaS Asher, R Shah, S Ings, et al.
Journal of the American College of Cardiology|March 24, 2018
Myocarditis in Patients Treated With Immune Checkpoint InhibitorsSyed S Mahmood, Michael G Fradley, Justine V Cohen, et al.
Clinical Radiology|November 26, 2025
Utility of diffusion-weighted signal intensity ratio measurements for predicting malignancy in adnexal mass lesions and its comparison with ORADS MRI scoring: Can an abbreviated MRI protocol predict malignancy accurately?N S Mahmood, A A Al Rashid, S B Ladumor, et al.
British Journal of Haematology|May 12, 2024
Atrial arrhythmias following CAR-chimeric antigen receptor T-cell therapy: Incidence, risk factors and biomarker profileRoni Shouval, Adam Goldman, Jessica R Flynn, et al.
Journal of the American College of Cardiology|December 21, 2019
Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T)Raza M Alvi, Matthew J Frigault, Michael G Fradley, et al.
Cancer Research|July 7, 2026
Targeting Cystine Addiction Suppresses Breast Cancer Lung MetastasisJosep Tarragó-Celada, Asad S Mahmood, Yulia Panina, et al.
JAMA|August 8, 2023
Atorvastatin for Anthracycline-Associated Cardiac Dysfunction: The STOP-CA Randomized Clinical TrialTomas G Neilan, Thiago Quinaglia, Takeshi Onoue, et al.
Pageof 31